Josh Mandel-Brehm, Camp4 CEO
With a fresh $100M in hand, one RNA startup is moving to the clinic, finding partners and building a new lab — all at once
Until 2020, Camp4 was in the business of creating maps of how cells turn genes on and off.
But then it changed course. “Following the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
